Drug intelligence / Profile preview

peanut allergen extract

Development stage
Discontinued
Lead developer
Aimmune Therapeutics
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Oral, Epicutaneous, Sublingual
01

Overview

Peanut allergen extract is a biological product derived from peanuts (*Arachis hypogaea*) containing a complex mixture of allergenic proteins, most notably Ara h 1, Ara h 2, and Ara h 3. It is used both diagnostically, in skin prick testing (SPT) to confirm peanut hypersensitivity, and therapeutically, as part of allergen-specific immunotherapy (AIT). The therapeutic formulation (standardized as Palforzia) is indicated to reduce the incidence and severity of allergic reactions, including anaphylaxis, following accidental exposure to peanuts in allergic individuals. The drug functions by inducing immunological desensitization; repeated and gradual exposure to increasing doses of the extract shifts the immune profile from a Th2-mediated allergic response to a Th1/Treg-mediated tolerant state. This process leads to an increase in allergen-specific IgG4 levels, induction of regulatory T-cells, and a reduction in IgE-mediated mast cell and basophil degranulation.

Brand names
Palforzia
Other names
peanut (Arachis hypogaea) allergen powder-dnfpArachis hypogaea allergen extractpeanut protein extractcrude peanut allergen extractcrude peanut protein extract
02

Targets

Peanut-specific IgE (Peanut-specific immunoglobulin E)

Beyond the preview

Go deeper on peanut allergen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on peanut allergen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call